Publication | Closed Access
Metronomic vinorelbine plus bevacizumab as salvage therapy for patients with metastatic breast cancer.
20
Citations
3
References
2011
Year
The combination of oral metronomic vinorelbine and bevacizumab has good tolerance but minimal activity in terms of objective responses in pretreated patients with MBC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1